BG61267B1 - Growth hormone crystals and method for production thereof - Google Patents

Growth hormone crystals and method for production thereof Download PDF

Info

Publication number
BG61267B1
BG61267B1 BG97281A BG9728193A BG61267B1 BG 61267 B1 BG61267 B1 BG 61267B1 BG 97281 A BG97281 A BG 97281A BG 9728193 A BG9728193 A BG 9728193A BG 61267 B1 BG61267 B1 BG 61267B1
Authority
BG
Bulgaria
Prior art keywords
crystals
concentration
mol
added
organic solvent
Prior art date
Application number
BG97281A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG97281A (bg
Inventor
Flemming Junker
Claus Friis Theisen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of BG97281A publication Critical patent/BG97281A/bg
Publication of BG61267B1 publication Critical patent/BG61267B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
    • C30B29/54—Organic compounds
    • C30B29/58—Macromolecular compounds
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Materials Engineering (AREA)
  • Metallurgy (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG97281A 1990-07-13 1993-01-12 Growth hormone crystals and method for production thereof BG61267B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK168790A DK168790D0 (en:Method) 1990-07-13 1990-07-13
PCT/DK1991/000203 WO1992000998A1 (en) 1990-07-13 1991-07-12 Growth hormone crystals and a process for production of these gh-crystals

Publications (2)

Publication Number Publication Date
BG97281A BG97281A (bg) 1994-03-24
BG61267B1 true BG61267B1 (en) 1997-04-30

Family

ID=8107212

Family Applications (1)

Application Number Title Priority Date Filing Date
BG97281A BG61267B1 (en) 1990-07-13 1993-01-12 Growth hormone crystals and method for production thereof

Country Status (17)

Country Link
US (1) US6117984A (en:Method)
EP (1) EP0540582B1 (en:Method)
JP (1) JP2524446B2 (en:Method)
AT (1) ATE110745T1 (en:Method)
AU (1) AU666465B2 (en:Method)
BG (1) BG61267B1 (en:Method)
CA (1) CA2086087C (en:Method)
DE (1) DE69103755T2 (en:Method)
DK (2) DK168790D0 (en:Method)
ES (1) ES2060399T3 (en:Method)
HU (2) HUT64086A (en:Method)
IE (1) IE67054B1 (en:Method)
NZ (1) NZ238904A (en:Method)
PT (1) PT98297B (en:Method)
RU (1) RU2108341C1 (en:Method)
WO (1) WO1992000998A1 (en:Method)
ZA (1) ZA915446B (en:Method)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6894023B1 (en) * 1990-07-13 2005-05-17 Novo Nordisk A/S Growth hormone crystals and a process for production of these GH-crystals
DK168790D0 (en:Method) * 1990-07-13 1990-07-13 Novo Nordisk As
DE10399015I1 (de) * 1991-12-20 2012-05-03 Novo Nordisk As Stabilisierte pharmazeutische formulierung, die wachstumshormon und histidin enthält
SE9302278D0 (sv) * 1992-10-28 1993-07-02 Kabi Pharmacia Ab Growth hormone
AU7871298A (en) 1996-12-20 1998-07-17 Takeda Chemical Industries Ltd. Method of producing a sustained-release preparation
US6541606B2 (en) 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
JP3723857B2 (ja) * 1998-02-04 2005-12-07 日本ケミカルリサーチ株式会社 ヒト成長ホルモン含有水性医薬組成物
US7101575B2 (en) 1998-03-19 2006-09-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
US6451347B1 (en) 1999-03-01 2002-09-17 Alkermes Controlled Therapeutics, Inc. Method for purifying human growth hormone
ATE226267T1 (de) * 1999-06-10 2002-11-15 Max Planck Gesellschaft Einkapselung von kristallen mit mehrschichtigem überzug
US6566329B1 (en) 1999-06-28 2003-05-20 Novo Nordisk A/S Freeze-dried preparation of human growth hormone
TWI283182B (en) 2000-08-07 2007-07-01 Nektar Therapeutics Inhalable spray dried 4-helix bundle protein powders having minimized aggregation
SE517422C2 (sv) 2000-10-06 2002-06-04 Bioglan Ab Farmaceutiskt acceptabel stärkelse
AU2001294459A1 (en) 2000-10-06 2002-04-15 Jagotec Ag A controlled-release, parenterally administrable microparticle preparation
SE517421C2 (sv) 2000-10-06 2002-06-04 Bioglan Ab Mikropartiklar, lämpade för parenteral administration, väsentligen bestående av stärkelse med minst 85 % amylopektin och med reducerad molekylvikt, samt framställning därav
SE518007C2 (sv) 2000-11-16 2002-08-13 Bioglan Ab Förfarande för framställning av mikropartiklar
US7105181B2 (en) 2001-10-05 2006-09-12 Jagotec, Ag Microparticles
SE0201599D0 (sv) 2002-03-21 2002-05-30 Skyepharma Ab Microparticles
SE0202719D0 (sv) * 2002-09-13 2002-09-13 Pharmacia Ab Process for mfg crystals of growth hormone
CA2512001A1 (en) * 2002-12-31 2004-07-22 Altus Pharmaceuticals Inc. Complexes of protein crystals and ionic polymers
KR20050090430A (ko) * 2002-12-31 2005-09-13 알투스 파마슈티컬스 인코포레이티드 인간 성장 호르몬 결정 및 이것의 제조 방법
ZA200505305B (en) * 2002-12-31 2007-07-25 Altus Pharmaceuticals Inc Human growth hormone crystals and methods for preparing them
US20050032698A1 (en) * 2003-07-14 2005-02-10 Nps Allelix Corp. Stabilized formulation of parathyroid hormone
AU2006330833A1 (en) * 2005-12-23 2007-07-05 Altus Pharmaceuticals Inc. Compositions comprising polycation-complexed protein crystals and methods of treatment using them
JP2010513309A (ja) * 2006-12-18 2010-04-30 アルタス ファーマシューティカルズ インコーポレイテッド ヒト成長ホルモン製剤

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA653324A (en) * 1962-12-04 G. Brink Norman Growth hormone and methods of preparing the same
US2143590A (en) * 1936-09-26 1939-01-10 Univ Alberta Insulin preparation and process of producing crystals of insulin
US2174862A (en) * 1938-12-30 1939-10-03 Frederick Stearns & Company Process of producing crystalline insulin
US2595278A (en) * 1950-04-28 1952-05-06 Armour & Co Preparation of insulin from pancreas glands
US3102077A (en) * 1953-08-19 1963-08-27 Christensen Henry Marinus Preparation of insulin containing 2.75 to 8 percent zinc content
US2897117A (en) * 1955-02-10 1959-07-28 Univ Alberta Insulin process
US3856771A (en) * 1973-07-16 1974-12-24 Lilly Co Eli Process for manufacturing alkali metal or ammonium insulin
KR890002631B1 (ko) * 1984-10-04 1989-07-21 몬산토 캄파니 생물학적으로 활성인 소마토트로핀을 지속적으로 유리하는 조성물
ATE62598T1 (de) * 1984-10-04 1991-05-15 Monsanto Co Verzoegerte freisetzung biologisch aktiver somatotropine.
IL79681A (en) * 1985-08-12 1991-06-10 Int Minerals & Chem Corp Transition metal complexes of growth hormones and their prolonged release compositions
HU203367B (en) * 1987-01-30 1991-07-29 Int Minerals & Chem Corp Process for obtaining somatotpropins from weak aqueous solution
US4764592A (en) * 1987-04-23 1988-08-16 Eli Lilly And Company Crystalline human proinsulin and process for its production
ES2154627T3 (es) * 1988-08-24 2001-04-16 American Cyanamid Co Estabilizacion de somatotropinas mediante la modificacion de restos de cisteina utilizando mutagenesis de localizacion dirigida o derivatizacion quimica.
US5109117A (en) * 1990-06-26 1992-04-28 Monsanto Company Method of somatotropin naturation using urea and a soluble organic alcohol
DK168790D0 (en:Method) * 1990-07-13 1990-07-13 Novo Nordisk As
US5780599A (en) * 1990-07-13 1998-07-14 Novo Nordisk A/S Growth hormone crystals and a process for production of growth hormone crystals

Also Published As

Publication number Publication date
BG97281A (bg) 1994-03-24
WO1992000998A1 (en) 1992-01-23
ZA915446B (en) 1992-03-25
ES2060399T3 (es) 1994-11-16
AU8284691A (en) 1992-02-04
EP0540582A1 (en) 1993-05-12
PT98297A (pt) 1992-05-29
HUT64086A (en) 1993-11-29
CA2086087C (en) 1999-09-14
DK0540582T3 (da) 1995-01-30
PT98297B (pt) 1999-01-29
IE912444A1 (en) 1992-01-15
US6117984A (en) 2000-09-12
JP2524446B2 (ja) 1996-08-14
CA2086087A1 (en) 1992-01-14
DE69103755T2 (de) 1995-02-23
NZ238904A (en) 1993-04-28
HU9300067D0 (en) 1993-04-28
DE69103755D1 (de) 1994-10-06
JPH05507497A (ja) 1993-10-28
RU2108341C1 (ru) 1998-04-10
EP0540582B1 (en) 1994-08-31
ATE110745T1 (de) 1994-09-15
DK168790D0 (en:Method) 1990-07-13
IE67054B1 (en) 1996-02-21
AU666465B2 (en) 1996-02-15
HU210323B (en) 1995-03-28

Similar Documents

Publication Publication Date Title
BG61267B1 (en) Growth hormone crystals and method for production thereof
RU2122426C1 (ru) Фармацевтический препарат, содержащий гормон роста или производное гормона роста и гистидин или производное гистидина, препарат, представляющий собой кристаллы гормона роста, содержащие гистидин или производное гистидина и способ получения кристаллов гормона роста и гистидина или производного гистидина
DE69620877T2 (de) Arzneimittelformulierungen für il-12
DE69432596T2 (de) Zusammensetzungen für verabreichung von osteogenen proteinen
DE68906153T2 (de) Humanes relaxinpräparat.
DE69414723T2 (de) Lyophilisierte stammzellenfaktor formulierungen
EP0682944A1 (fr) Formulation stable lyophilisée comprenant une protéine; kit de dosage
DE3729863A1 (de) Stabilisierte erythropoietin-lyophilisate
JP3702313B2 (ja) ゴナドトロピン含有薬剤組成物
US5780599A (en) Growth hormone crystals and a process for production of growth hormone crystals
DE69636739T2 (de) Verfahren zur rückfaltung von menschlichem activin a
DE69313444T2 (de) IL-6 ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN stabilisiert mit einem nicht-reduzierenden Zucker
JPH03505334A (ja) 凍結乾燥されたペプチド製剤
DE69322654T2 (de) Verfahren zur herstellung von kristallen des wachstumshormones und die so erhaltenen kristalle
DE69425581T2 (de) Methode zur stabilisierung von protein c oder aktiviertem protein c und stabilisierte verbindungen
US4355025A (en) Biologically active amides
US6894023B1 (en) Growth hormone crystals and a process for production of these GH-crystals
US6605594B2 (en) Aqueous glycerol formulations of somatotropin
WO1998029131A9 (en) Aqueous glycerol formulations of somatotropin
JP2006513986A (ja) 成長ホルモンの結晶を製造するための方法
PL171356B1 (pl) Sposób wytwarzania kryształów hormonu wzrostu lub pochodnych hormonu wzrostu i histydyny lub pochodnej histydyny